For nearly 50 years, the successes and failures of 3M have been part of an exclusive report card for the entire American economy.
As one of just 30 members of the Dow Jones industrial average stock index, the Maplewood-based conglomerate's swings have influenced investors, bankers, regulators and lawmakers on a daily basis.
That position of prestige could be in jeopardy.
By the end of the year, 3M plans to spin off its health care division — a quarter of the company's $34 billion in annual revenue. The company's stock price has also suffered a 36% decline in the past five years, the worst performance among the index's companies.
The keepers of the Dow — owned and run by S&P Global — don't tip off their intentions ahead of any changes, which do not occur on any set schedule.
"Changes in response to corporate actions and market developments can be made at any time," reads the official index methodology. "Any potential impacts on index constituents from a spin-off are evaluated by the Index Committee on a case-by-case basis."
3M has the second-longest current tenure on the Dow. Only Procter & Gamble — maker of Tide, Pampers and Olay — has been included longer among current members.
Since 3M was added to the index in 1976, the Dow's makeup has changed 22 times, including in 2012 when UnitedHealth Group, Minnesota's largest company, was added.